CAPRI2010
The Center for Antibody Production Rijeka: Upgrading the Central Research and Service Infrastructure for the South Eastern Region of Europe
| Coordinatore | "SVEUCILISTE U RIJECI, MEDICINSKI FAKULTET"
Organization address
address: "B. Branchetta, 20 20" contact info |
| Nazionalità Coordinatore | Croatia [HR] |
| Totale costo | 775˙700 € |
| EC contributo | 619˙770 € |
| Programma | FP7-REGPOT
Specific Programme "Capacities": Research potential of Convergence Regions |
| Code Call | FP7-REGPOT-2008-1 |
| Funding Scheme | CSA-SA |
| Anno di inizio | 2009 |
| Periodo (anno-mese-giorno) | 2009-03-01 - 2012-02-29 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
"SVEUCILISTE U RIJECI, MEDICINSKI FAKULTET"
Organization address
address: "B. Branchetta, 20 20" contact info |
HR (RIJEKA) | coordinator | 619˙770.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The Center for Proteomics was established at the Medical Faculty, University of Rijeka in 2006 with focus on monoclonal antibodies (mAb) development for cutting-edge applications including proteome analysis. Since its inception, the Center has succeeded in establishing several high level scientific collaboration projects in the Region and EU. The most important project is aimed at the development of mAbs against the entire Varicella Zoster Virus proteome. The Center has now several hundred hybridoma cell lines at its disposal secreting mAbs to a large variety of target proteins. This collection will soon be made available to the scientific community. The Center is a member of 'ProteomeBinders', an EU FP6 CA project, aimed at planning a resource of affinity reagents for analysis of the human proteome. Thus, the Center is strategically positioned to serve as a key resource for basic and clinical scientists in the Region and an important resource to the European scientific community. CAPRI2010 will extend the mission of the Center in order to attract scientists and enterprises from the Region and from the whole of Europe with interests in the fields of mAb technology and proteome analysis. It will enable the Center to achieve self sustainability on the long run. The key activities of CAPRI2010 consist in the establishment of new scientific collaboration in mAb development and application, e.g. in proteome analysis. Through the support intended by this REGPOT call, the entire region will benefit from the activities of the Center through (1) upgrading the infrastructural resources and (2) mobilizing human resources by providing special training and education. The Center is unique and will therefore optimally serve the development of research and technological potential in the South Eastern Europe through aggregation of knowledge and resources, thus enhancing the capacity and competitiveness of these countries to participate and contribute to future EU research projects.'